ТАГРИССО
Country: Belarus
Language: Russian
Source: Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)
Summary of Product characteristics
(SPC)
04-03-2021
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Osimertinib
Available from:
AstraZeneca AB, Швеция
INN (International Name):
Protein kinase inhibitors; Osimertinib
Class:
оригинальное
Prescription type:
по рецепту
Manufactured by:
AstraZeneca AB, Швеция
Therapeutic area:
Ингибиторы протеинкиназы
Product summary:
Нормативная документация: НД РБ 9517-2021
Authorization date:
2021-02-24
